# GTF2I

## Overview
The GTF2I gene encodes the general transcription factor IIi (TFII-I), a multifunctional transcription factor involved in various cellular processes, including gene expression regulation, signal transduction, and cell cycle control. TFII-I is characterized by its complex structure, which includes multiple I-repeats with helix-loop-helix motifs, a leucine zipper for dimerization, and a DNA binding domain, allowing it to interact with both proteins and nucleic acids (Doi‐Katayama2007Solution; Cheriyath2001StructureFunction). The protein is involved in signal-dependent transcription and plays a critical role in cellular proliferation, differentiation, and survival by binding to specific DNA elements such as the Initiator (Inr) and E-box (Roy2012Biochemistry; Roy2007Signalinduced). TFII-I's activity is modulated by post-translational modifications, including phosphorylation, which affects its nuclear localization and transcriptional activity (Shirai2017Role). The gene is associated with several clinical conditions, including thymic epithelial tumors, autoimmune diseases, and genetic disorders like Williams-Beuren syndrome, highlighting its significance in human health and disease (Roy2017Pathophysiology; Petrini2014A).

## Structure
The GTF2I gene encodes a protein with a complex molecular structure characterized by several specific features. The protein contains six I-repeats, each with a potential helix-loop-helix (HLH) motif, which facilitates protein-protein interactions and DNA binding (Doi‐Katayama2007Solution; Cheriyath2001StructureFunction). The primary structure includes a basic region preceding the second I-repeat, which is postulated to be a DNA binding domain (Cheriyath2001StructureFunction). The tertiary structure of the fifth I-repeat has been elucidated using NMR spectroscopy, revealing a new fold consisting of four helices and two antiparallel beta strands, forming a hydrophobic core (Doi‐Katayama2007Solution).

GTF2I also contains an N-terminal leucine zipper motif, which is involved in homomeric and heteromeric interactions, contributing to its quaternary structure (Cheriyath2001StructureFunction; Shirai2017Role). The protein undergoes post-translational modifications, including phosphorylation at specific residues, which influences its transcriptional activity and nuclear localization (Doi‐Katayama2007Solution; Shirai2017Role).

The GTF2I gene produces several splice variant isoforms, such as α, β, γ, and Δ, which differ in their amino acid sequences and functional properties (Cheriyath2000Alternatively; Makeyev2009Alternative). These isoforms exhibit differential regulation of gene expression and are influenced by extracellular signals (Cheriyath2001StructureFunction).

## Function
The GTF2I gene encodes the transcription factor TFII-I, which plays a significant role in regulating gene expression in healthy human cells. TFII-I is involved in signal-dependent transcription, crucial for cellular processes such as proliferation, differentiation, and survival. It functions both in the cytoplasm and the nucleus, where it binds to specific DNA elements like the Initiator (Inr) and E-box, influencing gene expression (Roy2012Biochemistry; Roy2007Signalinduced).

TFII-I is a key regulator of the cell cycle, particularly through its role in the transcriptional activation of cyclin D1, which is essential for the G1-S transition. It is recruited to the cyclin D1 promoter in response to growth factor signals, and its activity is modulated by phosphorylation on specific tyrosine residues (Roy2012Biochemistry). TFII-I also interacts with phospholipase C-gamma in the cytoplasm, affecting calcium entry into the cell, which highlights its role as a signaling intermediary (Roy2007Signalinduced).

In response to genotoxic stress, TFII-I undergoes ubiquitination and degradation, a process mediated by the p53 and ATM pathways, which is crucial for cell cycle arrest (Roy2012Biochemistry). This degradation is necessary for maintaining genomic stability and proper cell cycle progression. TFII-I's involvement in these molecular processes underscores its importance in cell biology and organismal development.

## Clinical Significance
Mutations and alterations in the GTF2I gene are linked to several diseases and conditions. In thymic epithelial tumors (TETs), particularly type A and AB thymomas, a specific missense mutation (Leu404His) is frequently observed. This mutation is associated with a favorable prognosis and better survival outcomes, as it prevents the degradation of the TFII-I protein, leading to increased expression and cell proliferation (Roy2017Pathophysiology; Petrini2014A). GTF2I mutations are also found in angioimmunoblastic T-cell lymphomas, where they may affect T cell receptor signaling (Nathany2020Gene).

GTF2I is implicated in autoimmune diseases such as primary Sjögren syndrome, systemic lupus erythematosus, and rheumatoid arthritis. Specific single nucleotide polymorphisms (SNPs) in GTF2I are associated with these conditions, potentially altering transcription factor binding sites and leading to aberrant expression (Roy2017Pathophysiology).

In genetic disorders, GTF2I is involved in Williams-Beuren syndrome, characterized by a hemizygous deletion on chromosome 7q11.23, and is linked to autism spectrum disorders. These conditions are associated with dosage effects of GTF2I, influencing social behavior and cognitive function (Roy2017Pathophysiology; Chailangkarn2018The).

## Interactions
The GTF2I protein, encoded by the GTF2I gene, is a multifunctional transcription factor that participates in various physical interactions with proteins and nucleic acids. It contains distinct domains for DNA-protein and protein-protein interactions, including a leucine zipper for homodimerization, a nuclear localization signal, and a DNA binding domain. GTF2I can form homomers and heteromers with its isoforms, enabling it to bind to different target promoters and drive the expression of various genes (Chailangkarn2018The).

GTF2I interacts with several proteins, including the CCCTC-Binding Factor (CTCF), Serum Response Factor (SRF), and PHOX1, and binds to the initiator element (Inr) and E-box in promoters. It also associates with the pleckstrin-homology (PH) domain of Bruton tyrosine kinase (Nathany2020Gene). In the context of B cell receptor (BCR) signaling, GTF2I interacts with Bruton's tyrosine kinase (Btk) and the transcription factor Bright, forming a protein complex at the immunoglobulin heavy chain (IgH) gene locus (Lee2021Dermatan).

GTF2I is involved in the phosphatidylinositol 3-kinase (PI3K) and transforming growth factor beta (TGFβ) signaling pathways, affecting genes like Pik3r1 and Shc1 (Chailangkarn2018The). It also regulates calcium homeostasis by modulating extracellular Ca2+ entry (SeguraPuimedon2013TFIII).


## References


[1. (Nathany2020Gene) Shrinidhi Nathany, Rupal Tripathi, and Anurag Mehta. Gene of the month:gtf2i. Journal of Clinical Pathology, 74(1):1–4, September 2020. URL: http://dx.doi.org/10.1136/jclinpath-2020-207013, doi:10.1136/jclinpath-2020-207013. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1136/jclinpath-2020-207013)

[2. (Roy2012Biochemistry) Ananda L. Roy. Biochemistry and biology of the inducible multifunctional transcription factor tfii-i: 10years later. Gene, 492(1):32–41, January 2012. URL: http://dx.doi.org/10.1016/j.gene.2011.10.030, doi:10.1016/j.gene.2011.10.030. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2011.10.030)

[3. (Cheriyath2001StructureFunction) Venugopalan Cheriyath and Ananda L. Roy. Structure-function analysis of tfii-i. Journal of Biological Chemistry, 276(11):8377–8383, March 2001. URL: http://dx.doi.org/10.1074/jbc.m008411200, doi:10.1074/jbc.m008411200. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m008411200)

[4. (Makeyev2009Alternative) Aleksandr V. Makeyev and Dashzeveg Bayarsaihan. Alternative splicing and promoter use in tfii-i genes. Gene, 433(1–2):16–25, March 2009. URL: http://dx.doi.org/10.1016/j.gene.2008.11.027, doi:10.1016/j.gene.2008.11.027. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2008.11.027)

[5. (Lee2021Dermatan) Jongmin Lee, Jung-hyun Rho, Michael H. Roehrl, and Julia Y. Wang. Dermatan sulfate is a potential regulator of igh via interactions with pre-bcr, gtf2i, and bip er complex in pre-b lymphoblasts. Frontiers in Immunology, May 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.680212, doi:10.3389/fimmu.2021.680212. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.680212)

[6. (Roy2007Signalinduced) Ananda L. Roy. Signal-induced functions of the transcription factor tfii-i. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1769(11–12):613–621, November 2007. URL: http://dx.doi.org/10.1016/j.bbaexp.2007.10.002, doi:10.1016/j.bbaexp.2007.10.002. This article has 46 citations.](https://doi.org/10.1016/j.bbaexp.2007.10.002)

[7. (Roy2017Pathophysiology) Ananda L. Roy. Pathophysiology of tfii-i: old guard wearing new hats. Trends in Molecular Medicine, 23(6):501–511, June 2017. URL: http://dx.doi.org/10.1016/j.molmed.2017.04.002, doi:10.1016/j.molmed.2017.04.002. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmed.2017.04.002)

[8. (Cheriyath2000Alternatively) Venugopalan Cheriyath and Ananda L. Roy. Alternatively spliced isoforms of tfii-i. Journal of Biological Chemistry, 275(34):26300–26308, August 2000. URL: http://dx.doi.org/10.1074/jbc.m002980200, doi:10.1074/jbc.m002980200. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m002980200)

[9. (SeguraPuimedon2013TFIII) Maria Segura-Puimedon, Cristina Borralleras, Luis A. Pérez-Jurado, and Victoria Campuzano. Tfii-i regulates target genes in the pi-3k and tgf-β signaling pathways through a novel dna binding motif. Gene, 527(2):529–536, September 2013. URL: http://dx.doi.org/10.1016/j.gene.2013.06.050, doi:10.1016/j.gene.2013.06.050. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2013.06.050)

[10. (Shirai2017Role) Yoshinori Shirai, Weidong Li, and Tatsuo Suzuki. Role of splice variants of gtf2i, a transcription factor localizing at postsynaptic sites, and its relation to neuropsychiatric diseases. International Journal of Molecular Sciences, 18(2):411, February 2017. URL: http://dx.doi.org/10.3390/ijms18020411, doi:10.3390/ijms18020411. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms18020411)

[11. (Chailangkarn2018The) Thanathom Chailangkarn, Chalongrat Noree, and Alysson R. Muotri. The contribution of gtf2i haploinsufficiency to williams syndrome. Molecular and Cellular Probes, 40:45–51, August 2018. URL: http://dx.doi.org/10.1016/j.mcp.2017.12.005, doi:10.1016/j.mcp.2017.12.005. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcp.2017.12.005)

[12. (Doi‐Katayama2007Solution) Yukiko Doi‐Katayama, Fumiaki Hayashi, Makoto Inoue, Takashi Yabuki, Masaaki Aoki, Eiko Seki, Takayoshi Matsuda, Takanori Kigawa, Mayumi Yoshida, Mikako Shirouzu, Takaho Terada, Yoshihide Hayashizaki, Shigeyuki Yokoyama, and Hiroshi Hirota. Solution structure of the general transcription factor 2i domain in mouse tfii‐i protein. Protein Science, 16(8):1788–1792, August 2007. URL: http://dx.doi.org/10.1110/ps.072792007, doi:10.1110/ps.072792007. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1110/ps.072792007)

[13. (Petrini2014A) Iacopo Petrini, Paul S Meltzer, In-Kyu Kim, Marco Lucchi, Kang-Seo Park, Gabriella Fontanini, James Gao, Paolo A Zucali, Fiorella Calabrese, Adolfo Favaretto, Federico Rea, Jaime Rodriguez-Canales, Robert L Walker, Marbin Pineda, Yuelin J Zhu, Christopher Lau, Keith J Killian, Sven Bilke, Donna Voeller, Sivanesan Dakshanamurthy, Yisong Wang, and Giuseppe Giaccone. A specific missense mutation in gtf2i occurs at high frequency in thymic epithelial tumors. Nature Genetics, 46(8):844–849, June 2014. URL: http://dx.doi.org/10.1038/ng.3016, doi:10.1038/ng.3016. This article has 188 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.3016)